STRATEC SE
ISIN: DE000STRA555
WKN: STRA55
19 March 2025 04:15PM

EQS-News: STRATEC ANNOUNCES CHANGES TO 2025 FINANCIAL CALENDAR

STRATEC SE · ISIN: DE000STRA555 · EQS - Company News
Country: Germany · Primary market: Germany · EQS NID: 2103158

EQS-News: STRATEC SE / Key word(s): Miscellaneous
STRATEC ANNOUNCES CHANGES TO 2025 FINANCIAL CALENDAR

19.03.2025 / 16:15 CET/CEST
The issuer is solely responsible for the content of this announcement.


STRATEC ANNOUNCES CHANGES TO 2025 FINANCIAL CALENDAR

Birkenfeld, March 19, 2025

STRATEC SE, Birkenfeld, Germany, (Frankfurt: SBS; Prime Standard, SDAX) is today announcing a postponement in the publication date for its 2024 Annual Report. Publication is now scheduled for April 29, 2025. This postponement is to be viewed in connection with the increased time and coordination required due to the change of external auditor (initial audit), as well as with capacity bottlenecks, some of which sickness-related, in the finance department.

Prior to publication of its Annual Report, STRATEC plans to publish its preliminary results for the 2024 financial year together with its guidance for 2025. The exact date for this publication will be announced in advance. Based on current information, STRATEC expects that the targets formulated for the 2024 financial year, namely consolidated sales to remain stable or decline slightly (on a constant-currency basis) and an adjusted EBIT margin of around 10.0% to 12.0%, have been met.

Given mandatory convocation deadlines, the new publication date for the 2024 Annual Report will also make it necessary to postpone the Annual General Meeting scheduled to take place on May 23, 2025. The 2025 Annual General Meeting will now be held on June 17, 2025.

ABOUT STRATEC
STRATEC SE (www.stratec.com) designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and life sciences. Furthermore, the company offers complex consumables for diagnostic and medical applications. For its analyzer systems and consumables, STRATEC covers the entire value chain – from development to design and production through to quality assurance.

The partners market the systems, software and consumables, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. STRATEC develops its products on the basis of patented technologies.

Shares in the company (ISIN: DE000STRA555) are traded in the Prime Standard segment of the Frankfurt Stock Exchange and are listed in the SDAX select index of the German Stock Exchange.

FURTHER INFORMATION IS AVAILABLE FROM:
STRATEC SE
Jan Keppeler, CFA | Investor Relations, Sustainability & Corporate Communications
Tel: +49 7082 7916-6515
ir@stratec.com
www.stratec.com



19.03.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: STRATEC SE
Gewerbestr. 37
75217 Birkenfeld
Germany
Phone: +49 (0)7082 7916 0
Fax: +49 (0)7082 7916 999
E-mail: info@stratec.com
Internet: www.stratec.com
ISIN: DE000STRA555
WKN: STRA55
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2103158

 
End of News EQS News Service

2103158  19.03.2025 CET/CEST

Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.

The most important financial data at a glance
  2019 2020 2021 2022 2023 2024 2025e
Sales1 214,16 250,10 287,34 274,63 261,91 257,62 258,00
EBITDA1,2 35,60 56,27 66,43 58,07 40,08 46,98 44,00
EBITDA-Margin3 16,62 22,50 23,12 21,15 15,30 18,24 17,05
EBIT1,4 17,19 33,68 48,18 41,14 22,39 27,54 26,00
EBIT-Margin5 8,03 13,47 16,77 14,98 8,55 10,69 10,08
Net Profit (Loss)1 14,41 25,18 39,96 29,22 13,07 16,02 15,40
Net-Margin6 6,73 10,07 13,91 10,64 4,99 6,22 5,97
Cashflow1,7 21,26 31,85 63,47 10,28 19,43 48,71 38,00
Earnings per share8 1,20 2,07 3,28 2,41 1,07 1,32 1,26
Dividend per share8 0,84 0,90 0,95 0,97 0,55 0,60 0,65
Quelle: boersengefluester.de and Company information
Explanation

1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de

Auditor: PricewaterhouseCoopers

All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.

INVESTOR-INFORMATION
©boersengefluester.de
Stratec
WKN ISIN Legal Type Marketcap IPO Recommendation Plus Code
STRA55 DE000STRA555 SE 266,87 Mio € 25.08.1998 Halten 8FWCVH7J+C5
* * *
PE 2026e PE 10Y-Ø BGFL-Ratio Shiller-PE PB PCF KUV
15,46 30,79 0,50 12,59 1,15 5,48 1,04
Dividends
Dividend '2023
in €
Dividend '2024
in €
Dividend '2025e
in €
Div.-Yield '2025e
in %
0,55 0,60 0,65 2,96%
Financial calendar
Annual General Meeting Q1-figures Q2-figures Q3-figures Annual press conference
27.06.2025 30.05.2025 19.08.2025 07.11.2025 19.05.2025
Performance
Distance 60-days-line Distance 200-days-line Performance YtD Performance 52 weeks IPO
Last Price (EoD)
+1,15%
21,95 €
ATH 147,40 €
-12,36% -15,02% -26,34% -34,58% +644,07%

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
          Qualitätsjournalismus · Made in Germany © 2025          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2025 by Gereon Kruse #BGFL